Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Mid-range Performer
872.0000 30.20 (3.59%)
NSE Oct 01, 2025 15:31 PM
Volume: 2.1M
 

logo
Laurus Labs Ltd.
01 Aug 2025, 12:00AM
872.00
3.59%
Deven Choksey
Revenue: Consolidated revenue for the quarter increased by 31.4% YoY (-8.8% QoQ) to INR 15,696 Mn., significant beat on our estimates (+15.0%), driven by strong outperformance in the Custom Synthesis and the Generic FDF segment.
Number of FII/FPI investors increased from 259 to 293 in Jun 2025 qtr.
More from Laurus Labs Ltd.
Recommended